Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.

Hdl Handle:
http://hdl.handle.net/10147/207485
Title:
Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.
Authors:
Tobin, Anne-Marie; Veale, Douglas J; Fitzgerald, Oliver; Rogers, Sarah; Collins, Paul; O'Shea, Donal; Kirby, Brian
Affiliation:
Department of Dermatology, St. Vincent's University Hospital, Elm Park, Dublin 4,, Ireland. tobin.annemarie@gmail.com
Citation:
J Rheumatol. 2010 Jul;37(7):1386-94. Epub 2010 May 15.
Journal:
The Journal of rheumatology
Issue Date:
1-Feb-2012
URI:
http://hdl.handle.net/10147/207485
DOI:
10.3899/jrheum.090822
PubMed ID:
20472927
Abstract:
OBJECTIVE: Patients with psoriasis and psoriatic arthritis (PsA) have an increased incidence of cardiovascular disease (CVD) and cardiovascular risk factors such as smoking, hypertension, and metabolic syndrome compared to the normal population. Patients with psoriasis and PsA may also have increased risk from nonconventional risk factors such as raised levels of homocysteine and excessive alcohol consumption. We conducted a comprehensive review of the literature on CVD and all cardiovascular risk factors in patients with psoriasis and PsA. METHODS: Data sources: All studies identified from a Medline (www.ncbi.nlm.nih.gov) search pertaining to CVD, individual risk factors in psoriasis, and PsA were included. Study selection: Studies included a healthy reference population, were published between 1975 and 2009, and were written in English. RESULTS: Our search yielded 14 studies that documented rates of CVD in patients with psoriasis and PsA compared to controls. Substantial evidence points to elevated risk of CVD in patients with psoriasis and PsA. CONCLUSION: It remains difficult to conclude if risk factors are caused by psoriasis or share a common pathogenesis. Physicians treating patients with psoriasis and PsA must be aware of all potential cardiovascular risk factors in their patients.
Language:
eng
MeSH:
Arthritis, Psoriatic/*complications; Cardiovascular Diseases/*etiology; Diabetes Mellitus/etiology; Humans; Hypertension/etiology; MEDLINE; Metabolic Syndrome X/etiology; Psoriasis/*complications; Review Literature as Topic; Risk Factors; Smoking/adverse effects
ISSN:
0315-162X (Print); 0315-162X (Linking)

Full metadata record

DC FieldValue Language
dc.contributor.authorTobin, Anne-Marieen_GB
dc.contributor.authorVeale, Douglas Jen_GB
dc.contributor.authorFitzgerald, Oliveren_GB
dc.contributor.authorRogers, Sarahen_GB
dc.contributor.authorCollins, Paulen_GB
dc.contributor.authorO'Shea, Donalen_GB
dc.contributor.authorKirby, Brianen_GB
dc.date.accessioned2012-02-01T10:29:10Z-
dc.date.available2012-02-01T10:29:10Z-
dc.date.issued2012-02-01T10:29:10Z-
dc.identifier.citationJ Rheumatol. 2010 Jul;37(7):1386-94. Epub 2010 May 15.en_GB
dc.identifier.issn0315-162X (Print)en_GB
dc.identifier.issn0315-162X (Linking)en_GB
dc.identifier.pmid20472927en_GB
dc.identifier.doi10.3899/jrheum.090822en_GB
dc.identifier.urihttp://hdl.handle.net/10147/207485-
dc.description.abstractOBJECTIVE: Patients with psoriasis and psoriatic arthritis (PsA) have an increased incidence of cardiovascular disease (CVD) and cardiovascular risk factors such as smoking, hypertension, and metabolic syndrome compared to the normal population. Patients with psoriasis and PsA may also have increased risk from nonconventional risk factors such as raised levels of homocysteine and excessive alcohol consumption. We conducted a comprehensive review of the literature on CVD and all cardiovascular risk factors in patients with psoriasis and PsA. METHODS: Data sources: All studies identified from a Medline (www.ncbi.nlm.nih.gov) search pertaining to CVD, individual risk factors in psoriasis, and PsA were included. Study selection: Studies included a healthy reference population, were published between 1975 and 2009, and were written in English. RESULTS: Our search yielded 14 studies that documented rates of CVD in patients with psoriasis and PsA compared to controls. Substantial evidence points to elevated risk of CVD in patients with psoriasis and PsA. CONCLUSION: It remains difficult to conclude if risk factors are caused by psoriasis or share a common pathogenesis. Physicians treating patients with psoriasis and PsA must be aware of all potential cardiovascular risk factors in their patients.en_GB
dc.language.isoengen_GB
dc.subject.meshArthritis, Psoriatic/*complicationsen_GB
dc.subject.meshCardiovascular Diseases/*etiologyen_GB
dc.subject.meshDiabetes Mellitus/etiologyen_GB
dc.subject.meshHumansen_GB
dc.subject.meshHypertension/etiologyen_GB
dc.subject.meshMEDLINEen_GB
dc.subject.meshMetabolic Syndrome X/etiologyen_GB
dc.subject.meshPsoriasis/*complicationsen_GB
dc.subject.meshReview Literature as Topicen_GB
dc.subject.meshRisk Factorsen_GB
dc.subject.meshSmoking/adverse effectsen_GB
dc.titleCardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.en_GB
dc.contributor.departmentDepartment of Dermatology, St. Vincent's University Hospital, Elm Park, Dublin 4,, Ireland. tobin.annemarie@gmail.comen_GB
dc.identifier.journalThe Journal of rheumatologyen_GB
dc.description.provinceLeinster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.